Eden Research has completed a placing and retail offer
Eden Research plc has raised funds to build on its achievements in seed treatment, expand the markets for its existing biopesticide products, as well as invest in further developing its bioinsecticide.
Eden is the UK’s only AIM-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.
Oaklins Cavendish, based in the UK, acted as nominated advisor in connection with Eden Research’s recent placing.
Talk to the deal team
Related deals
Creo Medical Group plc has completed a US$15.7 million equity fundraise
Creo Medical Group plc, the provider of pioneering endoscopic healthcare solutions to clinicians and healthcare providers across the world, has completed a US$15.7 million (£12.1 million) equity fundraise.
Learn moreColt CZ Group has raised just under US$96 million in equity through an ABB
Colt CZ Group has raised just under US$96 million (€89 million) in equity through an accelerated bookbuild (ABB) offering of 3.9 million shares, representing 6.9% of the existing capital.
Learn moreLumiforte partners with Kartesia to propel global growth and innovation
Lumiforte, a global leader in innovative smart coatings for greenhouse horticulture, sports line-marking and other functional coatings for agriculture and industry, is excited to announce an investment from Kartesia, a European specialist in capital solutions for small and medium-sized companies. Horticoop, a longstanding shareholder of Lumiforte and a key player in the horticultural industry through its investment cooperative, continues to remain a shareholder.
Learn more